HERSHEY TRUST COHERSHEY TRUST CO

Institutional investor · Portfolio as of Q4 2022

SEC EDGAR SourceSEC Filings

Top Holdings7 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
HSHSYFBDelisted

HERSHEY COMPANY CLASS B

58.1M$13.5B99.8%
16 qtrssince 2019-Q1
Unchanged
0
745,424$16.7M0.1%
Unchanged
0

AIRBNB INC-CLASS A

53,248$4.6M0.0%$167.33-48.90%
6 qtrssince 2021-Q3
Unchanged
0

NU HOLDINGS LTD/CAYMAN ISL-A

390,266$1.6M0.0%$4.070.00%
1 qtr
New
38

CRISPR THERAPEUTICS AG

33,758$1.4M0.0%$121.82-66.63%
8 qtrssince 2021-Q1
Unchanged
0

MICROSOFT CORP

2,272$544,8710.0%$198.35+142.17%
10 qtrssince 2020-Q3
Unchanged
0

DIDI GLOBAL INC ADR

36,072$114,7090.0%$2.94+38.78%
4 qtrssince 2022-Q1
Unchanged
0
$13.5B
AUM
7
Positions
Q4 2022
Filing
Rating · 2.0
Quarterly Portfolio Change
-2%Q3'21$10.4B+14%Q4'21$11.9B+10%Q1'22$13.1B-3%Q2'22$12.7B+1%Q3'22$12.8B+5%Q4'22$13.5B
Activity profile
$ moved · Q4'22
New10%Increased0%Decreased0%Exited90%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.8 years
<1Q14%1-4Q14%1-2Y14%2Y+57%

HERSHEY TRUST CO manages $13.5B across 7 positions as of Q4 2022. Top holdings: HSYFB (99.8%), MEITUAN DIANPING USD0.00001 (A (0.1%), ABNB (0.0%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q4 2022 Summary

Active quarter - 1 new positions, 9 exits, 0 increased. No standout high-conviction moves this quarter. Portfolio: $13.5B across 7 positions.

Top holdings by portfolio weight

Total AUM$13B
HSYFB99.82%
MEITUAN DIAN0.12%
ABNB0.03%
NU0.01%
CRSP0.01%
MSFT0.00%
DIDIY0.00%
CMCSA0.00%
UBER0.00%
TDOC0.00%

Portfolio allocation by GICS sector

Sectors5
Unknown99.94%
Consumer Cyclical0.03%
Financial Services0.01%
Healthcare0.01%
Technology0.00%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction39
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used